Información del artículo
Artículo
Opciones para acceder a los textos completos de la publicación Medicina Clínica
Suscriptor
Comprar
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
References
[1]
B. Hanley, A. Truesdale, A. King, D. Elbourne, I. Chalmers.
Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey.
BMJ, 322 (2001), pp. 519-523
[2]
S. Staniszewska.
Patient and public involvement in health services and health research: a brief overview of evidence, policy and activity.
J Res Nurs, 14 (2009), pp. 295-298
[3]
M.J. Goldfarb, C. Bechtel, Q. Capers IV, A. Velasco, J.A. Dodson, J.L. Jackson, et al.
Engaging families in adult cardiovascular care: a scientific statement from the American Heart Association.
J Am Heart Assoc, 11 (2022), pp. e025859
[4]
Increasing patient, public involvement in clinical research.
Lancet Health Long, 5 (2024), pp. e83
[5]
K.L. Shaw, M.J. Calvert, P. Borrow, E. Chakera, R. Chakraverty, S.E. Hughes, et al.
Integrating patient and public involvement and engagement in translational medicine.
Lancet, 404 (2024), pp. 828-830
[6]
National Institute for Health Research. Resources and training for public involvement. Available from: https://www.learningforinvolvement.org.uk/.
[7]
Patient-Centered Outcomes Research Institute (PCORI). Available from: https://www.pcori.org/.
[8]
M.S.Y. Biddle, A. Gibson, D. Evans.
Attitudes and approaches to patient and public involvement across Europe: a systematic review.
Health Soc Care Comm, 29 (2021), pp. 18-27
[9]
J.P. Domecq, G. Prutsky, T. Elraiyah, Z. Wang, M. Nabhan, N. Shippe, et al.
Patient engagement in research: a systematic review.
BMC Health Serv Res, 14 (2014), pp. 89
[10]
N. Benizri, S. Hallot, K. Burns, M. Goldfarb.
Patient and family representation in randomized clinical trials published in 3 medical and surgical journals. A systematic review.
JAMA Netw Open, 5 (2022), pp. e2230858
[11]
C. De Angelis, J.M. Drazen, F.A. Frizelle, C. Haug, J. Hoey, R. Horton, et al.
Clinical trial registration: a statement from the International Committee of Medical Journal Editors.
Ann Intern Med, 141 (2004), pp. 477-478
[12]
World Medical Association. Declaration of Helsinki.
Ethical principles for medial research involving human participants. Helsinki, (2024),
[13]
World Health Organization. ICTRP. Trial registration. Available from: https://www.who.int/clinical-trials-registry-platform/network/trial-registration.
[14]
R. Dal-Ré, R. Banzi, I.A. Cristea, C. Fernández-de-las-Casas, L.G. Hemkens, P. Janiaud, et al.
Using the phases of clinical development of medicines to describe clinical trials assessing other interventions is widespread but not useful.
J Clin Epidemiol, 161 (2023), pp. 157-163
[15]
H.P. Soares, S. Daniels, A. Kumar, M. Clarke, C. Scott, S. Swann, et al.
Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group.
BMJ, 328 (2004), pp. 22e4
[16]
K.E. Dengso, S.T. Lindholm, S.F. Herling, M. Pedersen, K.H. Norskov, M.O. Collet, et al.
Patient and public involvement in Nordic healthcare research: a scoping review of contemporary practice.
Res Involv Engagem, 9 (2023), pp. 72
[17]
L.P. Forsythe, K.L. Carman, V. Szydlowski, L. Fayish, L. Davidson, D.H. Hickman, et al.
Patient engagement in research: early findings from the patient-centered outcomes research institute.
Health Aff (Millwood), 3 (2019), pp. 359-367
[18]
M. Husson, A. Dechartres, B. Ramjdee, M. Diverres, T. Zejli, M. L’Henaff, et al.
Patient and public involvement is suboptimal in randomized controlled trials addressing a chronic condition.
J Clin Epidemiol, 160 (2023), pp. 71-82
[19]
I. Lang, A. King, G. Jenkins, K. Boddy, Z. Khan, K. Liabo.
How common is patient and public involvement (PPI)? Cross-sectional analysis of frequency of PPI reporting in health research papers and associations with methods, funding sources and other factors.
BMJ Open, 12 (2022), pp. e063356
[20]
S. Estrup, E. Baror, C.B. Mortensen, C.T. Anthon, E. Crescioli, M.B.N. Kjaer, et al.
Patient and public involvement in contemporary large intensive care trials: A meta-epidemiological study.
Acta Anaesthesiol Scand, 67 (2023), pp. 256-264
[21]
S.G. Nicholls, A.A. Al-Jaishi, H. Niznick, K. Carroll, M.T. Madani, K.D. Peak, et al.
Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: results from a methodological review.
Alzheimer's Dement, 15 (2023), pp. e12392
[22]
T.M. Zirnsak, A.H. Ng, C. Brasier, R. Gray.
Public involvement in Australian clinical trials: a systematic review.
Clin Trials, 21 (2024), pp. 507-515
[23]
A.W. Karlsson, A.K. Sorensen, K. Borgesen, K.E. Behrens, T. Andersen, M.L. Kidholm, et al.
Roles, outcomes, and enablers within research partnerships: a rapid review of the literature on patient and public involvement and engagement in health research.
Res Involv Engagem, 9 (2023), pp. 43
[24]
G. Fox, M.M. Lalu, T. Sabloff, S.G. Nicholls, M. Smith, D. Stacey, et al.
Recognizing patient partner contributions to health research: a systematic review of reported practices.
Res Involv Engagem, 9 (2023), pp. 80
[25]
S.M. Vanderhout, M. Bhalla, A. Van, D.A. Fergusson, B.K. Potter, A. Karoly, et al.
The impact of patient and family engagement in child health research: a scoping review.
J Pediatr, 253 (2023), pp. 115-128
[26]
A.W. Chan, I. Boutron, S. Hopewell, D. Moher, K.F. Schulz, G.S. Collins, et al.
SPIRIT 2025 statement: updated guideline for protocols of randomized trials.
BMJ, 389 (2025), pp. e081477
[27]
S. Hopewell, A.-W. Chan, G.S. Collins, A. Hróbjartsson, D. Moher, K.F. Schulz, et al.
CONSORT 2025 statement: updated guideline for reporting randomised trials.
BMJ, 389 (2025), pp. e081123
[28]
R. Dal-Ré, E. García-Méndez, I. Mahillo-Fernández.
Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literature.
Eur J Clin Pharmacol, 81 (2025), pp. 429-439
[29]
E. Doble, S. Walker, A. Price, K. Abbasi.
More medical journals must work in partnership with patients and the public.
BMJ, 386 (2024), pp. q1463
[30]
J. Brennan, M.T.C. Poon, E. Christopher, O. Fulton, C. Porteous, P. Brennan.
Reporting of PPI and the MCID in phase III/IV randomised controlled trials—a systematic review.
Trials, 24 (2023), pp. 370
[31]
O. Zvonareva, C. Cravet, D.P. Richards.
Practices of patient engagement in drug development: a systematic scoping review.
Res Involv Engagem, 8 (2022), pp. 29
[32]
M. Mavris, A.F. Helms, N. Bere.
Engaging patients in medicines regulation: a tale of two agencies.
Nat Rev Drug Discov, 18 (2019), pp. 885-886
